Learning Center

Learning Center

The Epredia Learning Center 

Explore recent articles.

Learning Center

Explore Epredia's latest articles 

The direct costs of a glass-slide workflow are easy to see on a budget line. The indirect costs are harder to see. FTE hours spent on retrieval, assembly, transport, and misfiling; TAT delays caused by physical logistics; and staff time lost to avoidable rework can have a substantial impact on lab efficiency, productivity, and costs. Read more.

At 500 or more slides per day, a glass slide workflow is not just inefficient - it is a structural capacity ceiling. The high-volume labs that are breaking through that ceiling without expanding their workforce are not managing their way out of the problem. They are engineering their way out of it. Read more.

Every pathology lab has at least one person whose departure would cause a service disruption. Usually more than one. The question for a lab manager is not whether staff will leave. The real question is whether the laboratory's workflows are robust enough to absorb that departure without creating a diagnostic crisis. Read more.

Manual lab quality control is the most underestimated productivity constraint in digital pathology. Every slide triggering a manual QC check, a rescanning decision, or a refocus intervention is a workflow interruption that costs staff time, creates process variability, and accumulates into a compounding throughput problem at scale. Read more.

Slide scanner capacity problems rarely announce themselves cleanly. They accumulate in overtime rosters, in backlog reports, in the quiet knowledge that the current setup cannot absorb the next growth step. Recognizing the signs early is the difference between a planned upgrade and a crisis response. Read more.

The labs that experience the smoothest digital pathology transitions do not succeed because the technology is simple. They succeed because they planned for the complexity before it became a problem and understood which risks were within their control to mitigate. Read more.

The digital pathology business case that gets approved is not the one with the most ambitious benefit projections. It is the one whose cost savings are conservative, independently sourced, and directly traceable to your lab’s operating model. Read more.